| Literature DB >> 31449058 |
Cecilia Domínguez Conde1,2, Özlem Yüce Petronczki1,2,3, Safa Baris4,5, Katharina L Willmann1,2, Enrico Girardi2, Elisabeth Salzer1,2,3,6, Stefan Weitzer7, Rico Chandra Ardy1,2,3, Ana Krolo1,2,3, Hanna Ijspeert8, Ayca Kiykim4,5, Elif Karakoc-Aydiner4,5, Elisabeth Förster-Waldl9, Leo Kager6, Winfried F Pickl10, Giulio Superti-Furga2,11, Javier Martínez7, Joanna I Loizou2, Ahmet Ozen4,5, Mirjam van der Burg8, Kaan Boztug1,2,3,6.
Abstract
Polymerase δ is essential for eukaryotic genome duplication and synthesizes DNA at both the leading and lagging strands. The polymerase δ complex is a heterotetramer comprising the catalytic subunit POLD1 and the accessory subunits POLD2, POLD3, and POLD4. Beyond DNA replication, the polymerase δ complex has emerged as a central element in genome maintenance. The essentiality of polymerase δ has constrained the generation of polymerase δ-knockout cell lines or model organisms and, therefore, the understanding of the complexity of its activity and the function of its accessory subunits. To our knowledge, no germline biallelic mutations affecting this complex have been reported in humans. In patients from 2 independent pedigrees, we have identified what we believe to be a novel syndrome with reduced functionality of the polymerase δ complex caused by germline biallelic mutations in POLD1 or POLD2 as the underlying etiology of a previously unknown autosomal-recessive syndrome that combines replicative stress, neurodevelopmental abnormalities, and immunodeficiency. Patients' cells showed impaired cell-cycle progression and replication-associated DNA lesions that were reversible upon overexpression of polymerase δ. The mutations affected the stability and interactions within the polymerase δ complex or its intrinsic polymerase activity. We believe our discovery of human polymerase δ deficiency identifies the central role of this complex in the prevention of replication-related DNA lesions, with particular relevance to adaptive immunity.Entities:
Keywords: Adaptive immunity; DNA repair; Genetic diseases; Genetics; Immunology
Mesh:
Substances:
Year: 2019 PMID: 31449058 PMCID: PMC6763221 DOI: 10.1172/JCI128903
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 14.808